Integrin β 4 is a controversial target for non–small cell lung cancer—reply
Year: 2016
Type: letter
Source: Human Pathology
Authors: Rachel L. Stewart, Kathleen L. O'Connor
Institutions: University of Kentucky, Markey Cancer Center
Language: English
Subfield: Immunology and Allergy
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2548891307